Influenza vaccination coverage among patients with diabetes mellitus in the Italian area of Udine, from 1 October to 31 December 2017
| Influenza vaccination | ||||
| No | Yes | Tot | P value | |
| N (%) | N (%) | N | ||
| Sex | 0.33 | |||
| Female | 3458 (47.4) | 3837 (52.6) | 7295 | |
| Male | 4012 (46.6) | 4593 (53.4) | 8605 | |
| Age category (years) | <0.001 | |||
| <18 | 73 (93.6) | 5 (6.4) | 78 | |
| 18–64 | 3583 (75.1) | 1188 (24.9) | 4771 | |
| 65–74 | 1696 (41.5) | 2778 (58.5) | 4747 | |
| 75–84 | 1380 (30.4) | 3153 (69.6) | 4533 | |
| ≥85 | 465 (26.3) | 1306 (73.7) | 1771 | |
| HbA1c | <0.001 | |||
| None in 365 days | 3175 (56.6) | 2434 (43.4) | 5609 | |
| <42 mmol/mol | 412 (46.7) | 471 (53.3) | 883 | |
| 42–48 mmol/mol | 759 (39.5) | 1161 (60.5) | 1920 | |
| 48–53 mmol/mol | 749 (40.2) | 1114 (59.8) | 1863 | |
| 53–64 mmol/mol | 1396 (40.9) | 2019 (59.1) | 3415 | |
| ≥64 mmol/mol | 979 (44.3) | 1231 (55.7) | 2210 | |
| Prescribed medications* | <0.001 | |||
| None in 2017 | 2383 (55.6) | 1904 (44.4) | 4286 | |
| I | 786 (45.9) | 925 (54.1) | 1711 | |
| M | 2004 (45.6) | 2388 (54.4) | 4392 | |
| O | 359 (39.9) | 541 (60.1) | 900 | |
| IM | 320 (42.0) | 442 (58.0) | 762 | |
| IO | 90 (36.7) | 155 (63.3) | 245 | |
| MO | 1233 (42.5) | 1666 (57.5) | 2899 | |
| IMO | 295 (41.9) | 409 (58.1) | 704 | |
| Latency from diagnosis | <0.001 | |||
| ≤1 year | 948 (59.4) | 648 (40.6) | 1596 | |
| >1 and ≤5 years | 1718 (50.8) | 1666 (49.2) | 3384 | |
| >5 and ≤10 years | 2005 (48.9) | 2093 (51.1) | 4098 | |
| >10 years | 2799 (41.0) | 4023 (59.0) | 6822 | |
| Total | 7470 (47.0) | 8430 (53.0) | 15 900 | |
HbA1c, glycated haemoglobin; I, insulin only; IM, insulin and metformin; IMO, insulin, metformin and other oral antidiabetic medications; IO, insulin and other oral antidiabetic medications; M, metformin only; MO, metformin and other oral antidiabetic medications; O, other oral antidiabetic drugs only.